Related Experiment Videos
Dihydrofolate reductase: x-ray structure of the binary complex with methotrexate
Summary
Dihydrofolate reductase features a central beta-pleated sheet. Its structure shows similarities to dinucleotide binding domains, with methotrexate binding in a hydrophobic pocket involving aspartic acid 27.
Area of Science:
- Biochemistry
- Structural Biology
- Enzymology
Background:
- Dihydrofolate reductase (DHFR) is a crucial enzyme in folate metabolism.
- Its polypeptide backbone folding involves a central eight-stranded beta-pleated sheet.
- Structural similarities exist between DHFR and dinucleotide binding domains of dehydrogenases.
Purpose of the Study:
- To elucidate the structural characteristics of dihydrofolate reductase.
- To investigate the binding interactions of methotrexate within the enzyme's active site.
- To compare the folding patterns of DHFR with related enzyme domains.
Main Methods:
- Analysis of the polypeptide backbone folding in dihydrofolate reductase.
- Geometric comparison of DHFR's beta-pleated sheet and helices with dinucleotide binding domains.
- Examination of methotrexate binding within the enzyme's cavity.
Main Results:
- The central eight-stranded beta-pleated sheet is a key structural feature of DHFR.
- DHFR's innermost four strands and two bridging helices share geometric similarity with dinucleotide binding domains but differ in connectivity.
- Methotrexate binds in a deep cavity, with its pteridine ring in a hydrophobic pocket, and forms a strong interaction with aspartic acid 27.
Conclusions:
- The unique folding of DHFR contributes to its function.
- Structural comparisons reveal evolutionary relationships and functional adaptations in enzyme families.
- Specific interactions between aspartic acid 27 and methotrexate highlight key binding determinants for enzyme inhibition.